Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

SHA:600332 Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 23.28B CNY in the quarter ending March 31, 2026, with 3.58% growth. This brings the company's revenue in the last twelve months to 78.46B, up 5.29% year-over-year. In the year 2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 77.66B with 3.55% growth.

• Revenue (ttm): 78.46B
• Revenue Growth: +5.29%
• P/S Ratio: 0.45
• Revenue / Employee: 2.90M
• Employees: 27,057
• Market Cap: 35.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	77.66B	2.66B	3.55%
Dec 31, 2024	74.99B	-522.58M	-0.69%
Dec 31, 2023	75.52B	4.73B	6.68%
Dec 31, 2022	70.79B	1.77B	2.57%
Dec 31, 2021	69.01B	7.34B	11.90%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 3, 2026

Data Sources Report a data error